Orchid Pharma Q4 FY26 Results: Net Profit ₹25.8 Cr, Down 24.1% YoY
Orchid Pharma Ltd reported revenue from operations of ₹368.3 Cr (+3.0% YoY) and net profit of ₹25.8 Cr (-24.1% YoY) for Q4 FY26.
- Key figure
- Net profit ₹25.8 Cr · -24.1% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Orchid Pharma Ltd reported revenue from operations of ₹368.3 Cr (+3.0% YoY) and net profit of ₹25.8 Cr (-24.1% YoY) for Q4 FY26.
Orchid Pharma Ltd reported revenue from operations of ₹304.2 Cr (+15.6% YoY) and net profit of ₹3.2 Cr for Q1 FY27.
Orchid Pharma Ltd reported revenue from operations of ₹237.6 Cr (+0.0% YoY) and net profit of ₹23.8 Cr (+6.7% YoY) for Q4 FY26.
Orchid Pharma approved audited FY2026 results and appointed T R Chadha & Co. LLP as internal auditors. The consolidated net profit for the year stood at ₹21.21 Crore.